Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 10:40 AM GMT"We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
Biocon, Mylan launch insulin biosimilar Semglee in Australia Medical Dialogues Bureau3 Oct 2019 10:21 AM GMTNew Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sep 2019 4:00 AM GMTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
Mylan launches generic version of Faslodex Injection to treat breast cancer Medical Dialogues Bureau19 Sep 2019 4:05 AM GMTNew Delhi: Mylan N.V. recently announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 4:00 AM GMTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 4:00 AM GMTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
Pfizer, Mylan in talks to merge off-patent drugs business Medical Dialogues Bureau29 July 2019 4:00 AM GMTMylan shareholders would receive a little more than 40 per cent of the newly formed entity, with Pfizer shareholders receiving the remainder, the...
DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug Farhat Nasim18 July 2019 10:28 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details Farhat Nasim27 Jun 2019 10:37 AM GMTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Dr Reddys launches generic version of Tobi in US market Farhat Nasim26 Jun 2019 9:37 AM GMTThe product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 12:43 PM GMTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 6:29 AM GMTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...